ReviewCurrent hematologic malignancy reports2021

Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same Job.

Melanie Schwerdtfeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.